Course Director:
Manju T. Beier, Pharm..D., FASCP
President, Geriatric Consultant Resources, LLC
Clinical Assistant Professor, College of Pharmacy
University of Michigan, Ann Arbor, Michigan, USA
Upon completion of this program, the participant should be able
to:
1. Describe the incidence and economic burden of osteoporosis and
osteoporotic fractures in the United States.
2. Discuss the bone remodeling process and describe the changes in
this process that result in osteoporosis.
3. Describe the pharmacologic effects of calcium and vitamin D on the
skeleton, and recite the NIH Consensus Conference guidelines
regarding optimal calcium intake.
4. Outline the guidelines from the American Association of Clinical
Endocrinologists, and the National Osteoporosis Foundation Consensus
Statement on the diagnosis, prevention, and management of
osteoporosis.
5. Describe the clinical effects of hormone replacement therapy with
respect to osteoporosis and coronary artery disease.
6. Discuss issues regarding the optimal age of initiation and
duration of hormone replacement therapy for osteoporosis prevention
and treatment.
7. Recite adverse effects commonly encountered with hormone
replacement therapy and outline a plan for managing these effects and
describe contraindications and precautions that should be considered
when instituting hormone replacement therapy.
8. Outline the role of bisphosphonates, calcitonin, selective
estrogen receptor modulators (SERMs), and fluoride, in the management
of osteoporosis, and describe their clinical efficacy, mechanisms of
action, precautions, administration guidelines, and adverse
effects.
9. Describe the role of flavonoids and other investigational drug
therapies in the prevention and/or treatment of postmenopausal bone
loss.
Target Audience
Geriatric health-care practitioners
Accreditation
At this time we are offering CE for pharmacists only. The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
First Release Date: May 1998
Second Release date: July 2002
Expiration Date: July 2005
This program (Program {INDIVIDUAL PROGRAM NUMBER #203-999-02-604-H01)} qualifies
for 0.15 CEUs (1.5 contact hours) of continuing pharmacy education.
CEUs will be awarded provided that the participant reviews this site and scores 70% or better on the post test that follows. To receive a statement of credit, please complete the examination and evaluation that follows this program. A statement will be awarded and mailed to you within 4-6 weeks.
The information provided in these programs is intended solely for
the continuing educational needs of health-care practitioners. The
medications discussed in these programs have Food and Drug
Administration approval in the US. Individuals should not exclusively
rely upon the information provided in these programs.
The continuing education programs are offered "as is." Geriatric
Consultant Resources, LLC disclaims all warranties and
representations, express or implied, with respect to the programs and
the information contained therein, including without limitation any
and all warranties of title, non infringement, merchantability, or
fitness for any particular purpose. Without limiting the foregoing,
Geriatric Consultant Resources LLC shall not be responsible for any
inaccuracy or omission in the information contained in the programs,
and shall have no liability whatsoever of any kind resulting from any
claim or action arising out of the use of the programs.
